Tocilizumab as a possible cause of ischemic colitis.

Forneiro Pérez, Rocío; Dabán López, Pablo; Zurita Saavedra, María Sol; Hernández García, María Dolores; Mirón Pozo, Benito

Tocilizumab as a possible cause of ischemic colitis. / Tocilizumab como posible causa de colitis isquémica.

Forneiro Pérez, Rocío; Dabán López, Pablo; Zurita Saavedra, María Sol; Hernández García, María Dolores; Mirón Pozo, Benito.

Forneiro Pérez R; Hospital Universitario Clínico San Cecilio, Granada, España. Electronic address: rocio.forneiro@gmail.com.
Dabán López P; Hospital Universitario Clínico San Cecilio, Granada, España.
Zurita Saavedra MS; Hospital Universitario Clínico San Cecilio, Granada, España.
Hernández García MD; Hospital Universitario Clínico San Cecilio, Granada, España.
Mirón Pozo B; Hospital Universitario Clínico San Cecilio, Granada, España.

Gastroenterol Hepatol ; 44(5): 373-374, 2021 May.

Article in English, Spanish | MEDLINE | ID: covidwho-921578

Subject(s)

Antibodies, Monoclonal, Humanized/adverse effects; COVID-19 Drug Treatment; Colitis, Ischemic/chemically induced; COVID-19/complications; Colitis, Ischemic/complications; Colitis, Ischemic/diagnostic imaging; Colonoscopy; Gastrointestinal Hemorrhage/etiology; Humans; Male; Middle Aged; Rectum

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Colitis, Ischemic / Antibodies, Monoclonal, Humanized / COVID-19 Drug Treatment Type of study: Case report Topics: Long Covid Limits: Humans / Male / Middle aged Language: English / Spanish Journal: Gastroenterol Hepatol Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google